Related Experiment Video
Updated: May 13, 2026

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
Advances in the targeting molecules modified chitosan-based nanoformulations
Hongliang Du1, Xiaoqing Cai, Guangxi Zhai
1Department of Pharmaceutics, College of Pharmacy, Shandong University, 44 Wenhua Xilu, Jinan 250012, China. professorgxzhai@yahoo.cn
Abstract:
Chitosan, a cationic polysaccharide, has prompted the continuous impetus for the development of safe and effective drug delivery systems due to its unique properties such as mucoadhesive feature, absorption enhancement and active functional groups for chemical modifications. By using chitosan-based nanoformulations, many studies have attempted to improve the dispersion of loaded hydrophobic drugs in aqueous environment, protect the encapsulated proteins and genes against enzymatic degradation, and increase their absorption by target tissues. It's noteworthy that the derivatization of chitosan-based carriers with a ligand leads to the selective targeting of the nanoformulations to selected cells, thereby facilitating far more sensitive internalization and localization of nanoformulations for diseases' diagnosis and treatment. As such, this review focuses on some of the most poignant reports of the utility of targeting molecules such as carbohydrates, antibodies, peptides and some small molecules in chitosan-based nanoformulations for targeted delivery. Additionally, the affinity mechanism of different targeting molecules and the pros and cons of their conjugation strategies will be illustrated summarily.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
